Corpus ID: 6311484

Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat.

@article{Monopoli1998CardiovascularPO,
  title={Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat.},
  author={A. Monopoli and C. Casati and G. Lozza and A. Forlani and E. Ongini},
  journal={The Journal of pharmacology and experimental therapeutics},
  year={1998},
  volume={285 1},
  pages={
          9-15
        }
}
  • A. Monopoli, C. Casati, +2 authors E. Ongini
  • Published 1998
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental therapeutics
  • We characterized the in vivo cardiovascular profile of SCH 58261, 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2, 4-triazolo[1,5-c] pyrimidine, a selective A2A adenosine receptor antagonist, in conscious, freely moving rats by use of the telemetry system. In normotensive rats, SCH 58261, at 10 mg/kg i.p., significantly (P < .05) inhibited hypotension and tachycardia induced by the A2A receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine (0.01 mg/kg i.p.), but not the… CONTINUE READING
    Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade
    • 376
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 43 REFERENCES
    The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
    • 190
    The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist
    • 340
    • Highly Influential
    In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist.
    • 63
    Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
    • 852
    Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine.
    • 32
    Pharmacology of adenosine A2A receptors.
    • 325
    Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
    • 108
    Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranes.
    • 48
    Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.
    • 127